Distribution of signal transducer and activator of transcription 6 gene G2964A polymorphism in Chinese patients with ulcerative colitis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 12, 2006, Pages 1854-1857

  Zhu, Jianbo ^a   Xia, Bing ^a,b   Guo, Qiusha ^a   Cheng, Hong ^a   Li, Jin ^a   Ye, Mei ^a   Hu, Zhengguo ^a   Zhang, Xiaolian ^b   Tan, Jingquan ^b  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Chinese; Genetic polymorphism; Signal transducer and activator of transcription 6 (STAT6); Ulcerative colitis

Indexed keywords

STAT6 PROTEIN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CHINESE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RACE DIFFERENCE; RESTRICTION MAPPING; ULCERATIVE COLITIS;

EID: 33750443293     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04427.x     Document Type: Article

References (28)

1. Satsangi J, Jewell DP, Bell JI. The genetics of inflammatory bowel disease. Gut 1997; 40: 572-4.
2. Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variant with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
3. Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-6.
4. Kraus J, Börner C, Giannini E et al. Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site. J. Biol. Chem. 2001; 276: 43901-8.
5. Kotanides H, Reich NC. Interleukin-4-induced STAT6 recognizes and activates a target site in the promoter of the interleukin-4 receptor gene. J. Biol. Chem. 1996; 271: 25555-61.
6. Duncan DD, Swain SL. Role of antigen-presenting cells in the polarized development of helper T cell subsets: evidence for differential cytokine production by Th0 cells in response to antigen presentation by B cells and macrophages. Eur. J. Immunol. 1994; 24: 2506-14.
7. Dent AL, Hu-Li J, Paul WE et al. T helper type 2 inflammatory disease in the absence of interleukin 4 and transcription factor STAT6. Proc. Natl. Acad. Sci. USA 1998; 95: 13823-8.
8. Lai SY, Molden J, Liu KD et al. Interleukin-4-specific signal transduction events are driven by homotypic interactions of the interleukin-4 receptor alpha subunit. EMBO J. 1996; 15: 4506-14.
9. Daniel C, Salvekar A, Schindler U. A gain-of-function mutation in STAT6. J. Biol. Chem. 2000; 275: 14255-9.
10. Zhang S, Lukacs NW, Lawless VA et al. Cutting edge: differential expression of chemokines in Th1 and Th2 cells is dependent on Stat6 but not Stat4. J. Immunol. 2000; 165: 10-14.
11. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand. J. Gastroenterol. Suppl. 1989; 170: 2-6.
12. Amoli M, Ollier WER, Hajeer AH. A novel PCR-RFLP assay for the detection of a polymorphism in the 3′ of STAT6 gene. Genes Immun. 2000; 1: 349-50.
13. Xia B, Crusius JB, Wu J et al. Signal transducer and activator of transcription 6 gene G2964A polymorphism and inflammatory bowel disease. Clin. Exp. Immunol. 2003; 131: 446-50.
14. Jong DJ, Franke B, Naber AH et al. No evidence for involvement of IL-4R and CD11B from the IBD1 region and STAT6 in the IBD2 region in Crohn's disease. Eur. J. Hum. Genet. 2003; 11: 884-7.
15. Tamura K, Suzuki M, Arakawa H et al. Linkage and association studies of STAT6 gene polymorphisms and allergic diseases. Int. Arch. Allergy Immunol. 2003; 131: 33-8.
16. Nagarkatti R, Ghosh B. Identification of single-nucleotide and repeat polymorphisms in two candidate genes, interleukin 4 receptor (IL4RA) and signal transducer and activator of transcription protein 6 (STAT6), for Th2-mediated diseases. J. Hum. Genet. 2002; 47: 684-7.
17. Gao PS, Heller NM, Walker W et al. Variation in dinucleotide (GT) repeat sequence in the first exon of the STAT6 gene is associated with atopic asthma and differentially regulates the promoter activity in vitro. J. Med. Genet. 2004; 41: 535-9.
18. Duetsch G, Illig T, Loesgen S et al. STAT6 as an asthma candidate gene: polymorphism-screening, association and haplotype analysis in a Caucasian sib-pair study. Hum. Mol. Genet. 2002; 11: 613-21.
19. Nagarkatti R, Rao C, Vijayan V et al. Signal transducer and activator of transcription 6 haplotypes and asthma in the Indian population. Am. J. Respir. Cell. Mol. Biol. 2004; 31: 317-21.
20. Shao C, Suzuki Y, Kamada F et al. Linkage and association of childhood asthma with the chromosome 12 genes. J. Hum. Genet. 2004; 49: 115-22.
21. Amoli MM, Hand S, Hajeer AH et al. Polymorphism in the STAT6 gene encodes risk for nut allergy. Genes Immun. 2002; 3: 220-4.
22. Romagnani S. Cytokines and chemoattractants in allergic inflammation. Mol. Immunol. 2002; 38: 881-5.
23. Shimoda K, van Deursen J, Sangster MY et al. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 1996; 380: 630-3.
24. Takeda K, Tanaka T, Shi W et al. Essential role of STAT6 in IL-4 signalling. Nature 1996; 380: 627-30.
25. Kaplan MH, Schindler U, Smiley ST et al. STAT6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 1996; 4: 313-19.
26. Nelms K, Keegan AD, Zamorano J et al. The IL-4 receptor: signaling mechanisms and biologic functions. Annu. Rev. Immunol. 1999; 17: 701-38.
27. Bacharier LB, Jabara H, Geha RS. Molecular mechanisms of immunoglobulin E regulation. Int. Arch. Allergy Immunol. 1998; 115: 257-69.
28. Hamelmann E, Gelfand EW. IL-5-induced airway eosinophilia - the key to asthma? Immunol. Rev. 2001; 179: 182-91.